Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
This entry describes the complex signaling network mediated by dermal papilla cell (DPC)-derived exosomes in the hair follicle microenvironment. These exosomes function as paracrine messengers, transporting a cargo of microRNAs and growth factors that regulate the activity of neighboring cells, such as hair matrix cells and outer root sheath cells (Hu et al., 2020, Bioactive Materials). Key signaling pathways involved in this process include the Wnt/β-catenin, Sonic Hedgehog (Shh), and Bone Morphogenetic Protein (BMP) pathways, which are critical for hair follicle morphogenesis and cycling (Zhou et al., 2018, Journal of Dermatological Science). Specifically, exosomal miRNAs like miR-218-5p have been shown to promote the transition from the telogen (resting) phase to the anagen (growth) phase by stabilizing β-catenin. In conditions such as androgenetic alopecia, the secretion and composition of these exosomes are often altered, contributing to the miniaturization of the hair follicle. Therapeutic approaches targeting these pathways involve the use of exogenous exosomes or the delivery of specific exosomal components to restore healthy signaling (Kwack et al., 2019, Journal of Investigative Dermatology). While not a single molecular target, this system represents a significant area of research in regenerative medicine for hair loss. Current challenges include the standardization of exosome isolation, characterization of the bioactive cargo, and ensuring long-term safety in clinical applications.
Activation of Wnt/β-catenin and Shh signaling pathways via exosomal delivery of miRNAs and growth factors to stimulate hair follicle regeneration.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Dermal papilla cell-derived exosome.